Literature DB >> 20530260

Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function.

Idil Aktan1, Alan Chant, Zachary D Borg, David E Damby, Paige C Leenstra, Graham W J Lilley, Graham W G Lilley, Joseph Petty, Benjamin T Suratt, Cory Teuscher, Edward K Wakeland, Matthew E Poynter, Jonathan E Boyson.   

Abstract

CD1d-restricted NKT cells make up an innate-like T cell subset that plays a role in amplifying the response of innate immune leukocytes to TLR ligands. The Slam locus contains genes that have been implicated in innate and adaptive immune responses. In this study, we demonstrate that divergent Slam locus haplotypes modulate the response of macrophages to the TLR4 ligand LPS through their control of NKT cell number and function. In response to LPS challenge in vivo, macrophage TNF production in Slam haplotype-2(+) 129S1/SvImJ and 129X1/SvJ mice was significantly impaired in comparison with macrophage TNF production in Slam haplotype-1(+) C57BL/6J mice. Although no cell-intrinsic differences in macrophage responses to LPS were observed between strains, 129 mice were found to be deficient in liver NKT cell number, in NKT cell cytokine production in response to the CD1d ligand alpha-galactosylceramide, and in NKT cell IFN-gamma production after LPS challenge in vivo. Using B6.129c1 congenic mice and adoptive transfer, we found that divergent Slam haplotypes controlled the response to LPS in vivo, as well as the diminished NKT cell number and function, and that these phenotypes were associated with differential expression of signaling lymphocytic activation molecule family receptors on NKT cells. These data suggest that the polymorphisms that distinguish two Slam haplotypes significantly modulate the innate immune response in vivo through their effect on NKT cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530260      PMCID: PMC3055558          DOI: 10.4049/jimmunol.0902658

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.

Authors:  G Eberl; H R MacDonald
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

2.  Transcriptional regulator Id2 controls survival of hepatic NKT cells.

Authors:  Laurel A Monticelli; Yang Yang; Jamie Knell; Louise M D'Cruz; Michael A Cannarile; Isaac Engel; Mitchell Kronenberg; Ananda W Goldrath
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

3.  alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.

Authors:  H Kitamura; A Ohta; M Sekimoto; M Sato; K Iwakabe; M Nakui; T Yahata; H Meng; T Koda; S Nishimura; T Kawano; M Taniguchi; T Nishimura
Journal:  Cell Immunol       Date:  2000-01-10       Impact factor: 4.868

4.  CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes.

Authors:  Patricia Barral; Paolo Polzella; Andreas Bruckbauer; Nico van Rooijen; Gurdyal S Besra; Vincenzo Cerundolo; Facundo D Batista
Journal:  Nat Immunol       Date:  2010-03-14       Impact factor: 25.606

5.  Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis.

Authors:  Chris M Olson; Tonya C Bates; Hooman Izadi; Justin D Radolf; Sally A Huber; Jonathan E Boyson; Juan Anguita
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

6.  The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock.

Authors:  Caroline K Hu; Fabienne Venet; David S Heffernan; Yvonne L Wang; Brian Horner; Xin Huang; Chun-Shiang Chung; Stephen H Gregory; Alfred Ayala
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

7.  Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.

Authors:  Liping Song; Shahab Asgharzadeh; Jill Salo; Kelly Engell; Hong-wei Wu; Richard Sposto; Tasnim Ara; Ayaka M Silverman; Yves A DeClerck; Robert C Seeger; Leonid S Metelitsa
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

8.  Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction.

Authors:  F Dieli; G Sireci; D Russo; M Taniguchi; J Ivanyi; C Fernandez; M Troye-Blomberg; G De Leo; A Salerno
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

9.  Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4).

Authors:  I Smirnova; A Poltorak; E K Chan; C McBride; B Beutler
Journal:  Genome Biol       Date:  2000-04-27       Impact factor: 13.583

10.  The UCSC Genome Browser database: update 2010.

Authors:  Brooke Rhead; Donna Karolchik; Robert M Kuhn; Angie S Hinrichs; Ann S Zweig; Pauline A Fujita; Mark Diekhans; Kayla E Smith; Kate R Rosenbloom; Brian J Raney; Andy Pohl; Michael Pheasant; Laurence R Meyer; Katrina Learned; Fan Hsu; Jennifer Hillman-Jackson; Rachel A Harte; Belinda Giardine; Timothy R Dreszer; Hiram Clawson; Galt P Barber; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

View more
  6 in total

1.  The role of CD1d-restricted NKT cells in the clearance of Pseudomonas aeruginosa from the lung is dependent on the host genetic background.

Authors:  Patrick Benoit; Vaia Yioula Sigounas; Jenna L Thompson; Nico van Rooijen; Matthew E Poynter; Matthew J Wargo; Jonathan E Boyson
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

2.  Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells.

Authors:  Oliver Dienz; Victoria L DeVault; Shawn C Musial; Somen K Mistri; Linda Mei; Aleksandr Baraev; Julie A Dragon; Dimitry Krementsov; Andre Veillette; Jonathan E Boyson
Journal:  J Immunol       Date:  2020-02-05       Impact factor: 5.422

3.  Translational control of NKT cell cytokine production by p38 MAPK.

Authors:  Viswas K Nagaleekar; Guadalupe Sabio; Idil Aktan; Alan Chant; Isaac W Howe; Tina M Thornton; Patrick J Benoit; Roger J Davis; Mercedes Rincon; Jonathan E Boyson
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

4.  Polymorphisms in the CD1d promoter that regulate CD1d gene expression are associated with impaired NKT cell development.

Authors:  Zachary D Borg; Patrick J Benoit; Graham W J Lilley; Idil Aktan; Alan Chant; Victoria L DeVault; Mercedes Rincon; Jonathan E Boyson
Journal:  J Immunol       Date:  2013-12-04       Impact factor: 5.422

5.  Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis.

Authors:  Sally Ann Huber; Brian Roberts; Mohamad Moussawi; Jonathan E Boyson
Journal:  Am J Pathol       Date:  2012-11-27       Impact factor: 4.307

6.  Extrinsic allospecific signals of hematopoietic origin dictate iNKT cell lineage-fate decisions during development.

Authors:  Beverly S I Strong; Tess J Newkold; Amanda E Lee; Lucas E Turner; Amir M Alhajjat; Jonathan W Heusel; Aimen F Shaaban
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.